<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.vettaintech.com/research/the-algorithmic-alchemist-extending-alpha-s-half-life-in-an-age-of-decay-1781129063893</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-10T22:04:24.000Z</news:publication_date>
      <news:title>The Algorithmic Alchemist: Extending Alpha&apos;s Half-Life in an Age of Decay</news:title>
      <news:keywords>alpha decay quantitative strategies, meta-learning systematic investing, adaptive alpha quant finance, Vetta Framework quant, half-life alpha signals, algorithmic trading evolution, market efficiency quant, computational arms race finance, quantitative strategy risks, investing in meta-learning</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.vettaintech.com/insights/the-great-energy-re-wiring-are-we-trading-one-monopoly-for-another-1781089365682</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-10T11:02:45.000Z</news:publication_date>
      <news:title>The Great Energy Re-Wiring: Are We Trading One Monopoly for Another?</news:title>
      <news:keywords>energy transition investment opportunities, decentralized power generation investing, grid infrastructure investment outlook, localized energy solutions financing, energy sector monopoly debate, renewable energy investment, power grid modernization, Vetta Investments, V-Rank Alpha, separately managed accounts</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.vettaintech.com/insights/biotech-s-new-dawn-over-3-500-phase-3-trials-reshaping-healthcare-investment-1781002922493</loc>
    <news:news>
      <news:publication>
        <news:name>Vetta Investments</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-09T11:02:02.000Z</news:publication_date>
      <news:title>Biotech&apos;s New Dawn: Over 3,500 Phase 3 Trials Reshaping Healthcare Investment</news:title>
      <news:keywords>biotech phase 3 trials investment opportunities, healthcare innovation investment strategy, genomics AI biotech investment, biotech sector investment 2023, healthcare investment, biotech stocks, medical devices, venture capital biotech, Vetta Investments, V-Rank Alpha</news:keywords>
    </news:news>
  </url>
</urlset>